Molecular mechanism underlying cAMP-induced amplification of IGF mitogenic activity through PI3-kinase binding protein, PI3KAP/XB130.
cAMP 通过 PI3 激酶结合蛋白 PI3KAP/XB130 诱导 IGF 有丝分裂活性放大的分子机制。
基本信息
- 批准号:21580345
- 负责人:
- 金额:$ 3.16万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2009
- 资助国家:日本
- 起止时间:2009 至 2011
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We previously demonstrated that long-term pretreatment of rat FRTL-5 thyroid cells with TSH or cAMP-generating reagents potentiated IGF-I-dependent DNA synthesis. Under this condition, cAMP treatment increased tyrosine phosphorylation of a 125 kDa protein(p125) and its association with a p85 regulatory subunit of phosphatidylinositol 3-kinase(p85 PI3K), which were suggested to be important for potentiation of DNA synthesis. This study was undertaken to identify p125 and to elucidate its roles in potentiation of DNA synthesis induced by IGF-I. Immunoprecipitated phosphotyrosyl p125 in cAMP-stimulated FRTL-5 cells, was shown by MALDI-TOF MS analysis, to be a rat orthologue of human XB130, which we named phosphatidylinositol 3-kinase-associated protein(PI3KAP). cAMP treatment elevated PI3KAP/XB130 mRNA and protein levels as well as tyrosine phosphorylation and PI3KAP/XB130 interaction with p85 PI3K, leading to increased PI3K activities. Importantly, PI3KAP/XB130 knockdown in FRTL-5 cells attenuated cAMP-dependent potentiation of IGF-I-induced DNA synthesis. Addition of Src family kinase inhibitors, PP1 or PP2, during cAMP treatment abolished tyrosine phosphorylation of PI3KAP/XB130 and its interaction with p85 PI3K. In addition, c-Src was associated with PI3KAP/XB130 and was activated in response to cAMP. Together, these data indicate that cAMP-dependent induction of PI3KAP/XB130 and its association with PI3K are required for enhancement of IGF mitogenic activities.
我们先前证明,用TSH或cAMP生成试剂长期预处理大鼠FRTL-5甲状腺细胞可以增强IGF-I依赖的DNA合成。在这种情况下,cAMP处理增加了125 kDa蛋白(P125)的酪氨酸磷酸化及其与磷脂酰肌醇3-激酶(P85 PI3K)调节亚基(P85 PI3K)的联系,这被认为对DNA合成的增强是重要的。本研究旨在鉴定p125并阐明其在IGF-I诱导的DNA合成中的作用。MALDI-TOF MS分析表明,cAMP刺激的FRTL-5细胞中免疫沉淀的磷酸化酪氨酰p125是人XB130的大鼠同源蛋白,我们将其命名为磷脂酰肌醇3-激酶相关蛋白(PI3KAP)。CAMP处理使PI3KAP/XB130基因和蛋白水平升高,酪氨酸磷酸化以及PI3KAP/XB130与P85 PI3K的相互作用增强,导致PI3K活性增强。重要的是,PI3KAP/XB130在FRTL-5细胞中的敲除减弱了IGF-I诱导的DNA合成中cAMP依赖的增强。在cAMP处理过程中加入Src家族激酶抑制剂PP1或PP2,可阻断PI3KAP/XB130的酪氨酸磷酸化及其与P85 PI3K的相互作用。此外,c-Src与PI3KAP/XB130相关,并被cAMP激活。综上所述,这些数据表明,依赖cAMP的PI3KAP/XB130的诱导及其与PI3K的结合是增强IGF有丝分裂活性所必需的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
KIBRA Suppresses Apical Exocytosis through Inhibition of aPKC Kinase Activity in Epithelial Cells
- DOI:10.1016/j.cub.2011.03.029
- 发表时间:2011-04
- 期刊:
- 影响因子:9.2
- 作者:Yohei Yoshihama;K. Sasaki;Yosuke Horikoshi;A. Suzuki;T. Ohtsuka;F. Hakuno;Shin-ichiro Takahashi;
- 通讯作者:Yohei Yoshihama;K. Sasaki;Yosuke Horikoshi;A. Suzuki;T. Ohtsuka;F. Hakuno;Shin-ichiro Takahashi;
GH or IGF-I represses 11beta-hydroxysteroid dehydrogenase type 1(HSD1)mRNA expression in 3T3-L1 and its activity in their homogenates.
GH 或 IGF-I 抑制 3T3-L1 中 11β-羟基类固醇脱氢酶 1 型 (HSD1) mRNA 表达及其匀浆中的活性。
- DOI:
- 发表时间:2009
- 期刊:
- 影响因子:0
- 作者:Morita J;Hakuno F;Hizuka N;Takahashi SI;Takano K
- 通讯作者:Takano K
Effect of Paraquat-Induced Oxidative Stress on Insulin Regulation of Insulin-Like Growth Factor-Binding Protein-1 Gene Expression
- DOI:10.3164/jcbn.09-97
- 发表时间:2010-03-01
- 期刊:
- 影响因子:2.4
- 作者:Kimura, Kumi;Katsumata, Yoshihito;Takenaka, Asako
- 通讯作者:Takenaka, Asako
Dietary protein deprivation upregulates insulin signaling and inhibits gluconeogenesis in rat liver
- DOI:10.1677/jme-10-0102
- 发表时间:2010-11-01
- 期刊:
- 影响因子:3.5
- 作者:Toyoshima, Yuka;Tokita, Reiko;Takahashi, Shin-Ichiro
- 通讯作者:Takahashi, Shin-Ichiro
Insulin receptor substrates form high-molecular-mass complexes that modulate their availability to insulin/insulin-like growth factor-I receptor tyrosine kinases
- DOI:10.1016/j.bbrc.2010.12.045
- 发表时间:2011-01-21
- 期刊:
- 影响因子:3.1
- 作者:Fukushima, Toshiaki;Arai, Toshiya;Takahashi, Shin-Ichiro
- 通讯作者:Takahashi, Shin-Ichiro
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAKUNO Fumihiko其他文献
HAKUNO Fumihiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAKUNO Fumihiko', 18)}}的其他基金
Clearance of insulin resistance by inhibiting diacylglycerol kinaseζ activity
通过抑制二酰甘油激酶 z 活性清除胰岛素抵抗
- 批准号:
19580324 - 财政年份:2007
- 资助金额:
$ 3.16万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
- 批准号:
10246864 - 财政年份:2020
- 资助金额:
$ 3.16万 - 项目类别:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
- 批准号:
10677761 - 财政年份:2020
- 资助金额:
$ 3.16万 - 项目类别:
Discovery, Regulation and Function of the PI 3-Kinase and AKT Pathway in Cancer
PI 3 激酶和 AKT 通路在癌症中的发现、调节和功能
- 批准号:
10471296 - 财政年份:2020
- 资助金额:
$ 3.16万 - 项目类别:
Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
设计用于治疗血液恶性肿瘤的 PI 3 激酶 δ (PI3Kdelta) 调节剂
- 批准号:
MC_PC_MR/S02607X/1 - 财政年份:2019
- 资助金额:
$ 3.16万 - 项目类别:
Research Grant
Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
PI 3-激酶亚型作为 dsRNA 传感和炎症的新型调节剂
- 批准号:
BB/R017972/1 - 财政年份:2018
- 资助金额:
$ 3.16万 - 项目类别:
Research Grant
Role of PTEN and PI-3 kinase in medulloblastomagenesis
PTEN 和 PI-3 激酶在髓母细胞瘤发生中的作用
- 批准号:
9312006 - 财政年份:2017
- 资助金额:
$ 3.16万 - 项目类别:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
PTEN 和 PI-3 激酶在髓母细胞瘤发生中的作用
- 批准号:
10681197 - 财政年份:2017
- 资助金额:
$ 3.16万 - 项目类别:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
PTEN 和 PI-3 激酶在髓母细胞瘤发生中的作用
- 批准号:
10231271 - 财政年份:2017
- 资助金额:
$ 3.16万 - 项目类别:
Role of PTEN and PI-3 Kinase in Medulloblastomagenesis
PTEN 和 PI-3 激酶在髓母细胞瘤发生中的作用
- 批准号:
10196616 - 财政年份:2017
- 资助金额:
$ 3.16万 - 项目类别:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
验证 Vps34 PI 3-激酶作为胰岛素增敏的新潜在药物靶点
- 批准号:
BB/M013278/1 - 财政年份:2016
- 资助金额:
$ 3.16万 - 项目类别:
Research Grant














{{item.name}}会员




